Role of inflammatory infiltrates in triple negative breast cancer: Table 1
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of inflammatory infiltrates in triple negative breast cancer: Table 1
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 68, Issue 7, Pages 506-510
Publisher
BMJ
Online
2015-03-07
DOI
10.1136/jclinpath-2015-202944
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
- (2014) Xi Chen et al. NATURE
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
- (2014) Hatem Soliman et al. PLoS One
- Gene Signatures in Breast Cancer: Current and Future Uses
- (2014) Enrique Espinosa Arranz et al. Translational Oncology
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
- (2013) A N Seo et al. BRITISH JOURNAL OF CANCER
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
- (2013) Hee Jin Lee et al. Journal of Breast Cancer
- Occurrence and significance of epithelial-mesenchymal transition in breast cancer
- (2013) Ioannis Roxanis JOURNAL OF CLINICAL PATHOLOGY
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Prognostic impact of FOXP3 expression in triple-negative breast cancer
- (2012) Soohyeon Lee et al. ACTA ONCOLOGICA
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers
- (2012) Raoul Droeser et al. BMC CANCER
- Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes
- (2012) Lars C. Hanker et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
- (2012) N R West et al. BRITISH JOURNAL OF CANCER
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer
- (2012) Rin Yamaguchi et al. HUMAN PATHOLOGY
- Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma
- (2012) Luc Bron et al. INTERNATIONAL JOURNAL OF CANCER
- Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages
- (2012) Delisha A. Stewart et al. MOLECULAR CANCER RESEARCH
- SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
- (2012) Marco Montagner et al. NATURE
- NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
- (2012) Foluso O. Ademuyiwa et al. PLoS One
- FOXP3 and survival in urinary bladder cancer
- (2011) Malin E. Winerdal et al. BJU INTERNATIONAL
- Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
- (2011) Makiko Ono et al. BREAST CANCER RESEARCH AND TREATMENT
- Lactoferrin-Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes
- (2011) N.-H. Ha et al. CANCER RESEARCH
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
- (2011) Asis Palazón et al. CLINICAL CANCER RESEARCH
- Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
- (2011) Thomas Karn et al. EUROPEAN JOURNAL OF CANCER
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour-infiltrating macrophages and clinical outcome in breast cancer
- (2011) S M A Mahmoud et al. JOURNAL OF CLINICAL PATHOLOGY
- Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers
- (2011) Yao-Tseng Chen et al. PLoS One
- Cancer-testis antigen expression in triple-negative breast cancer
- (2010) G. Curigliano et al. ANNALS OF ONCOLOGY
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
- (2010) Sahar M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem Cells
- (2010) J. M. Reiman et al. CANCER RESEARCH
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry
- (2009) Daniela M. Schulz et al. JOURNAL OF PROTEOME RESEARCH
- Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth
- (2009) Robbert G. van der Most et al. PLoS One
- CT-X antigen expression in human breast cancer
- (2009) A. Grigoriadis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alarmins link neutrophils and dendritic cells
- (2009) De Yang et al. TRENDS IN IMMUNOLOGY
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
- (2008) Sandra D Bohling et al. MODERN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started